Liu Shi
VP of Frontage China, Biology & Pharmacology
Mrs. Shi has accumulated rich experience in the early stage of drug development activity screening, focusing on the development and validation of various in vitro screening systems related to drug development targets such as GPCR, nuclear receptor, enzymology and high throughput screening.
Mrs. Shi graduated from Beijing Institute of genome research, Chinese Academy of Sciences.